Overview

This trial is active, not recruiting.

Condition kidney failure
Treatment far infrared radiation (5μm to 20μm wavelength)
Phase phase 1
Sponsor GAAD Medical Research Institute Inc.
Start date February 2008
End date October 2008
Trial size 10 participants
Trial identifier NCT00599391, GAAD-RF-CTP1

Summary

Renal failure or kidney failure is a situation in which the kidneys fail to function adequately. It is divided into acute and chronic forms; either form may be due to a large number of other medical problems.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment
Arm
(Other)
Far Infrared Radiation
far infrared radiation (5μm to 20μm wavelength)
Far Infrared Radiation for 30 to 40 minutes per session.

Primary Outcomes

Measure
Kidney Function Improvement
time frame: 1 year

Secondary Outcomes

Measure
Causes of Mortality
time frame: 1 year

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - People with kidney diseases Exclusion Criteria: - None

Additional Information

Official title Phase 1 Study to Examine the Use of Far Infrared Radiation for Renal Failure.
Description There are many causes of chronic kidney disease. The most common cause is diabetes mellitus. Acute renal failure is a rapidly progressive loss of renal function, generally characterized by body fluids disturbances and electrolyte derangement. It is believed that far infrared radiation of the central nervous system, the endocrine system and the kidneys will help in the management of renal failure and a possible cure.
Trial information was received from ClinicalTrials.gov and was last updated in January 2009.
Information provided to ClinicalTrials.gov by GAAD Medical Research Institute Inc..